Thrombin alfa - ZymoGenetics
Alternative Names: Recombinant thrombin - ZymoGenetics; Recothrom; rhThrombinLatest Information Update: 05 Nov 2023
At a glance
- Originator ZymoGenetics
- Developer Bayer HealthCare; ZymoGenetics
- Class Antihaemorrhagics; Blood coagulation factors; Serine endopeptidases
- Mechanism of Action Fibrin stimulants; Serine endopeptidase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Surgical blood loss
Most Recent Events
- 19 Mar 2018 Baxter International completes the acquisition of thrombin alfa (RECOTHROM) from Mallinckrodt
- 08 Jan 2018 Baxter International entered into an agreement to acquire thrombin alfa from Mallinckrodt for Surgical blood loss
- 01 Feb 2016 Mallinckrodt plc acquired the haemostasis portfolio of The Medicines Company